In this week’s issue:
- Please see the attached message from the Office of the Vice-President Research & International regarding Major External Research Awards & Resources.
- Peter Wall Institute for Advanced Studies – Wall Scholars Research Award (final reminder)
- Weston Brain Institute – 2015 Transformational Research (final reminder)
- Bladder Cancer Advocacy Network – John Quale Travel Fellowships
- Saving Lives at Birth: A Grand Challenge for Development
- Scoliosis Research Society – New Investigator Grants
- March of Dimes – Request for Proposals
- Weston Brain Institute – MEchanisms of cellular death in NeuroDegeneration (MEND)
- Michael J. Fox Foundation – Parkinson’s Biomarkers and Outcomes Measures Research
Awards and Honours:
- Keio University – Keio Medical Science Prize
- Canadian Medical Hall of Fame – Call for Nominations
- Centre for Blood Research Seminar Series – Polyanionic cofactors of the serpin, C1-inhibitor, for the treatment of inflammatory diseases
- Centre for Blood Research Seminar Series – Biomechanics of bleeding
- Child & Family Research Institute, Providence Health Care Research Institute, and Vancouver Coastal Health Research Institute – Annual Public Lecture: Breathe into Research (reminder)
- Canadian Institutes of Health – Visit to UBC
- UBC Faculty of Medicine Continuing Professional Development – 12th Annual Pediatric Emergency Medicine Update: Pediatric Infections in the ER
- UBC Faculty of Medicine Continuing Professional Development – UBC Sexual Health 2015: Building Clinician Confidence & Competence (reminder)
Deadline: March 1, 2015
The Peter Wall Institute for Advanced Studies’ Wall Scholars Research Award is available to full-time UBC faculty members to spend one year in residence at the Peter Wall Institute, in a collaborative, interdisciplinary environment. The award offers seed foundational support for research projects that are expected to have a significant impact on scholarship and society. The Institute offers a welcoming, supportive and stimulating environment for UBC scholars to meet, to share and support individual research, to encourage ongoing serendipitous interactions, to extend the frontiers of research, and to promote engagement in cutting-edge research across disciplines. It provides UBC scholars, at all stages of their career, with the sustained opportunity to exchange ideas with national and international scholars, to engage in intellectual risk-taking and to work together on high-impact innovative research.
Up to fifteen Wall Scholars will be appointed for the period August 1 2015 to July 31 2016, each with up to $20,000 in research funding. Additional funding may be available for special interdisciplinary projects while scholars are in residence.
- Excellent research record
- A commitment to research outside usual disciplinary boundaries
- Excellence in proposal for innovative research during residency
- Must be a tenured or tenure-streamed UBC faculty member
LOI Deadline: March 3, 2015; 2pm EST
The prevalence of neurodegenerative diseases of aging is high and growing rapidly. This Program aims to support innovative ideas that can advance the development of scientific breakthroughs to accelerate the creation of safe, effective treatments for these diseases. The Program will support world-class projects with excellent preliminary data and significant potential to accelerate the development of therapeutics to treat one or more neurodegenerative diseases of aging.
Applicants can request a total of $400,000 to $1,500,000 over up to 3 years per project.
Proposed projects must be translational research in neurodegenerative diseases of aging and fall into one of two categories to be eligible for funding:
- Preclinical development of a therapeutic. For example, drugs (including small molecules, biologics, cell therapies and vaccines), medical devices or surgical intervention
- Development of tools that help accelerate development of therapeutics. For example, animal models, imaging techniques or reagents, biomarkers, and diagnostics
For more information, please visit the Weston Brain Institute website.
Deadline: March 18, 2015
The John Quale Travel Fellowship Program is a special opportunity for early career investigators interested in bladder cancer research to attend the annual Bladder Cancer Think Tank Meeting.
The $1,700 travel fellowships awarded each year are intended to defray travel-related costs for attending the meeting. Hosted by the Bladder Cancer Advocacy Network (BCAN), the primary mission of this meeting is to enhance collaboration among physicians and researchers who are dedicated to the prevention, diagnosis, and treatment of bladder cancer. This is a unique opportunity to meet and learn from leaders in the field. The Travel Fellowship Program seeks to engage more early-career individuals with interests related to bladder cancer including basic scientists, urologists, oncologists, and pathologists. Please contact BCAN at email@example.com if you have questions.
For further information, please visit the BCAN website.
LOI Deadline: March 27, 2015; 2pm EST
USAID, the Government of Norway, the Bill & Melinda Gates Foundation, Grand Challenges Canada, and DFID have joined together to launch Saving Lives at Birth: A Grand Challenge for Development, to find the tools and approaches to help the mothers and newborns during their most vulnerable hours.
We seek groundbreaking prevention and treatment approaches for pregnant women and newborns in poor, hard-to-reach communities around the time of delivery.
This is the period when the majority of maternal and newborn deaths occur and the population that has been the most difficult to reach.
We seek innovative ideas that can leapfrog conventional approaches in three main domains: (1) technology; (2) service delivery; and (3) “demand side” innovation that empowers pregnant women and their families to practice healthy behaviors and be aware of and access health care during pregnancy, childbirth and the early postnatal period, especially the first two days after birth.
For further information , please visit the Saving Lives at Birth website.
Deadline: April 1, 2015
The Scoliosis Research Society seeks applications for its New Investigator grant program.
Grants of up to $25,000 for up to two years will be awarded to new investigators in support of research projects related to scoliosis and/or other spinal deformities. Research topics may include but are not limited to evidence-based medicine; idiopathic scoliosis; etiology; non-op and operative treatment; 3D deformity of the spine and thorax; adult deformity; treatment and outcomes; osteoporosis, including osteoporotic spine fractures, how it impacts scoliosis kyphosis management, and/or how it relates to spinal deformity and instrumentation; early onset scoliosis treatment; sagittal imbalance; congenital scoliosis; neuromuscular spinal deformity; deformity and reconstruction arising from spine and sacral tumor treatment; thoracic insufficiency in children associated with spinal deformity; and pulmonary outcome sequelae following common natural history of spine deformity and treatment history.
A new investigator is defined as someone who is either a fellow or within ten years of completion of a fellowship or equivalent specialist training in their country and who has not previously been awarded funding from a major grantmaking organization. Applicants do not need to be members of the SRS, but they do need to have at least one SRS member on their team as a co-investigator.
For complete program guidelines and application instructions, please visit the SRS website.
LOI Deadline: April 30, 2015
March of Dimes invites all qualified scientists with faculty appointments or the equivalent, at universities, hospitals and research institutions (not for profit or profit), to submit applications for research grants relevant to our mission. This encompasses basic biological processes governing differentiation and development, genetics and genomics of these processes, clinical studies, reproductive health and environmental toxicology, and social and behavioral studies concerning cognitive and behavioral risks that affect outcomes of pregnancy, the perinatal period, and subsequent child development. Applications will be directed to one of three committees whose respective foci are:
- Cell Lineage and Differentiation
- Gene Discovery and Translational Medicine
- Social and Behavioral Sciences. This involves family units and includes genes, toxicants, social determinants that adversely affect language or behavior, especially if involving premature infants or children with birth defects.
For further information, including the procedure to submit a letter of intent, please visit http://www.marchofdimes.org/materials/research-program-request-for-proposals.pdf.
LOI Deadline: May 8, 2015; 5pm EST
The “MEchanisms of cellular death in NeuroDegeneration” (MEND) funding program’s overall goal is to discover and understand the mechanisms and pathophysiological processes by which brain cell loss is mediated in disease and thereby seek insights and potential targets for therapeutic interventions that would sustain healthy brain function.
The MEND Initiative invites research proposals that will explore brain cell death mechanisms in neurodegenerative diseases. We seek proposals that have some, or preferably all of the following characteristics:
- Use in vitro models with high construct validity to the disease process, for example, iPSC brain cells harbouring autosomal dominant mutations that cause disease in humans.
- Involve in vitro phenotypic systems that have in vivo correlates allowing translational studies.
- Use technologies that might serve as target discovery engines with the potential to uncover signalling/ intracellular pathways that are activated during brain cell death.
- Provide model systems with the potential to test hypotheses: for example, the use of RNAi or compound screening.
- Use in vivo models that have face and construct validity to human diseases that are amenable to cell death pathway investigations.
- Include in vivo models that lend themselves to research technologies that permit unbiased investigations of brain cell death mechanisms, e.g., model organisms that can be genetically manipulated rapidly and at scale.
- Allow a multisystem interrogation of brain cell death, e.g., in vitro, to ex vivo, to in vivo investigations that permit the systematic translation of findings.
- Employ experimental paradigms that produce quantitative data that are highly replicable.
This MEND does not seek proposals that:
- Are focused on ischemic brain cell cell death, as typified by stroke.
- Are focused on brain cell cell death mediated by acute trauma.
- Are focused on brain cell cell death mediated by autoimmune inflammatory processes, such as occurs in multiple sclerosis.
- Involve the extracellular or in vivo application of exogenous beta-amyloid peptide to cells.
The total sum available for this award program will be up to USD$1.25 million available over three years. MEND is looking to fund either a consortium of investigative teams or individual team-based projects ranging between USD$100,000-$1,250,000. The project budget should be in line with the proposed project goals with clear justification of the required resources to achieve those goals.
For further information, Please visit the Weston Brain Institute website.
Deadline: May 27, 2015
The Michael J. Fox Foundation is accepting applications for support of projects toward improved biomarker tools and clinical outcome measures to assist in clinical trial design, execution and interpretation of results.
Proposals should fall into one of the following categories:
- Imaging studies to develop or validate ligands for disease-modifying or symptomatic targets
- Clinical/physiological studies to develop or refine practical outcome measures or functional scales
- Biochemical or genetic assay studies to develop or refine platforms to analyze tissues or biofluids
Deadline for applications is May 27.
The Foundation will hold an informational conference call on March 26 to answer questions on the funding program. RSVP to firstname.lastname@example.org for call-in details.
For further information, please visit the Michael J. Fox Foundation website.
AWARDS AND HONOURS:
Nomination Deadline: March 10, 2015
The Keio Medical Science Prize gives recognition to the outstanding and creative achievements of researchers in the field of the medical and life sciences, in particular those contributing to scientific developments in medicine. It aims to promote worldwide advances in life sciences and medicine, to encourage the expansion of researcher networks throughout the world, and to contribute to the well-being of humankind.
Each laureate receives a certificate of merit, medal, and a monetary award of 10 million yen.
For guidelines on making a nomination, please visit the Keio Medical Science Prize website.
Nomination Deadline: June 29, 2015
The Canadian Medical Hall of Fame invites you to nominate someone, living or posthumous, whose contributions to medicine and the health sciences have led to extraordinary improvements in human health. Candidates are recognized for their innovative leadership in one or more of the following categories:
- Leadership in building excellence in health for Canadians and the world
- Leadership in health promotion, illness prevention and care
- Leadership in research with national and international recognition for a scientific contribution
Deadline for the 2016 Induction: Monday, June 29, 2015
For more information about our nomination process, visit www.cdnmedhall.org/nominate
Centre for Blood Research Seminar Series – “Polyanionic cofactors of the serpin, C1-inhibitor, for the treatment of inflammatory diseases” and “Novel complement inhibitors of haematophagous arthropods”
Date & Time: February 23, 2015, 12-1pm
Location: LSC 3, Life Sciences Centre, 2350 Health Sciences Mall, Vancouver
Dr. Robert Pike
Director, La Trobe Institute for Molecular Science
Head of School – Molecular Sciences
Dr. Lakshmi Wijeyewickrema
La Trobe University
Please see attached Poster for further details.
Centre for Blood Research Seminar Series – Biomechanics of bleeding
Date & Time: February 25, 2015, 12-1pm
Location: LSC 3, Life Sciences Centre, 2350 Health Sciences Mall, Vancouver
Dr. Nathan White
Assistant Professor, Division of Emergency Medicine
Adjunct Assistant Professor, Biomechanical and Mechanical Engineering
University of Washington
For some, the immediate reaction to the sight of bleeding is to grasp and compress the wound. Others react internally by slowing the heart rate and dropping their blood pressure, often followed by fainting. What appear to be puzzling reactions were more likely programmed into our physiology thousands of years ago to improve survival after injury. Fundamentally, bleeding is the balance between the outward forces of blood leaving the wound balanced against the resistive forces of the incipient hemostatic clot. We study these fundamental relationships focusing on platelet and fibrin interactions. We will present data from models of massive hemorrhage, peer into wounds to image clot formation in real time, and present new designs for hemostatic bandages. By understand-ing the fundamental relationships between clot formation, wound geometry, and blood flow, we can better design rationale therapies to stop bleeding. With this understanding, it is apparent that our puzzling reactions to bleeding actually make perfect sense.
Please contact Dr. Christian Kastrup (email@example.com) to network with the guest speaker.
Date & Time: March 4, 2015; 7-8:30pm (doors open at 6pm)
Location: Paetzold Auditorium, Vancouver General Hospital, 890 West 12th Avenue, Vancouver
An informative evening talk with today’s research leaders in lung health. Learn about the health resources and research findings that are empowering people living with or caring for others with lung diseases.
Lecture hosted by Dr. John Fleetham. Come and meet our featured speakers: Dr. Chris Carlsten, Dr. Don Sin, and Dr. Pascal Lavoie.
Please RSVP at www.vchri.ca/celebrateresearch.
Date & Time: March 25, 2015; 1:30-3:30pm
Location: Room 1002, Life Sciences Building, 2350 Health Sciences Mall, Vancouver
You are invited to an open session being presented by Dr. Jane Aubin, Chief Scientific Officer at the Canadian Institutes for Health Research (CIHR). Dr. Aubin will review recent and upcoming changes in CIHR funding and answer your questions.
Dr. Aubin’s talk will be video-conferenced from Life Sciences Institute (room 1002) to:
- BC Children’s and Women’s Hospital (CSB V2-222)
- Paul’s Hospital (SPH 1500 LT)
- Vancouver General Hospital – Diamond Health Care Centre (2263)
- UBC-Okanagan campus (DVC Boardroom, ADM 101)
Researchers, research grants facilitators, and graduate students are welcome.
If you are interested in attending, please RSVP at the following link: http://research.ubc.ca/vpri/cihr-visit-ubc
Date: May 8-9, 2015; APLS: May 7, 2015
Location: UBC Robson Square, Vancouver
Target audience: Pediatricians, emergency physicians, family physicians, & post graduate residents
Up to 11.25 Mainpro-M1/ MOC Section 1
Date: May 29-30, 2015
Location: UBC Robson Square, Vancouver
Target audience: Family Physicians, Nurse Practitioners, Midwives, Registered Nurses, Specialists, Residents & Other Allied Health Professionals
Up to 12.25 MainPro-M1/ MOC Section 1